Surface Oncology, Inc. (SURF)
Today's Latest Price: $7.86 USD
Updated Nov 23 4:00pm
Add SURF to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
Surface Oncology Inc (SURF) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SURF.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 5 | $15 | $9 | $12.4 | $7.72 | 60.62% |
SURF Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.08 | 5 | 1 | 0 | 0 | 0 | 6 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Surface Oncology Inc's percent of analysts bearish on the stock is lower than almost 100% of all US stocks.
- The percentage of analysts bullish on the stock of SURF is greater than 82.11% of all US stocks.
- The upside potential (average analyst target price relative to current price) of SURF is greater than 78.4% of all US stocks.
- The variance in analysts' estimates of SURF is lower than 22.84% of stocks in the small market cap category.
- The average analyst price target of SURF is greater than 27.73% of all US stocks.
- The number of analysts covering the stock of SURF is greater than 67.32% of stocks in the small market cap category.
- SURF has a less change in bullishness amongst analysts than almost 100% of all US stocks.
Stocks similar to Surface Oncology Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MNKD, CGEN and DRRX.
Is SURF a Buy, Hold or Sell? See the POWR Ratings now!
